Skip to content

Effectiveness of exercise therapy in hip osteoarthritis

Effectiveness of exercise therapy in hip osteoarthritis: a randomised controlled trial in primary health care

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN05601287
Enrollment
120
Registered
2009-04-07
Start date
2005-07-04
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the hip Musculoskeletal Diseases Coxarthrosis

Interventions

The intervention group received 12 supervised, (once per week, sustaining 45 minutes), rehabilitation sessions at baseline and four additional booster sessions at a point one year later. A physiothera
they were recommended to perform strengthening exercise with maximum speed and power. Each training session started with a warm-up session with marching in place using arms as part of the movement for

Sponsors

Mikkeli Central Hospital (Finland)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Both males and females, aged from 55 to 80 years 2. Unilateral or bilateral radiographic hip OA (X-ray less than 3 years old) 3. Pain experience in the hip region within the preceding month as indicated in the clinical criteria of the American College of Rheumatology

Exclusion criteria

Exclusion criteria: 1. Total hip replacement 2. Rheumatoid arthritis 3. Cognitive impairment 4. Major surgical operation within the preceding 6 months in the lower limb or lower back area 5. Acute or sub-acute lower back pain 6. Cardiovascular or pulmonary disease or some other chronic disease that would prevent full participation in the training programme

Design outcomes

Primary

MeasureTime frame
1. Self-reported pain and disease specific physical function were assessed by using the pain and functioning subscales of the WOMAC 2. Self-reported generic physical function was assessed by using the physical function score of the Finnish-validated SF-36 (36-item) Health Survey 3. Economic effectiveness was assessed by evaluating the number of doctor visits (associated with hip OA) and physiotherapy (sum score of using physiotherapy including exercise programme and/or inpatient rehabilitation associated with hip OA). The need of surgery (total hip replacement) and drug use (non-opioid analgesic (paracetamol, non steroidal anti-inflammatory drugs [NSAIDs]) and weak opioid (tramadol, codeine) concerning hip OA were also assessed. Assesssed at the following timepoints: 0, 3, 6, 12, 18, 24 and 36 months.

Secondary

MeasureTime frame
Objective functional scores: 1. Passive internal rotation and flexion of the hip joint 2. Extensor power of lower limb 3. Six Minute Walk Test (6MWT) 4. Ten-Metre Walk Test 5. Timed Up & Go (TUG) test 6. Sock Test Assessed at the following timepoints: 0, 3, 12, 24 and 36 months.

Countries

Finland

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026